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Two crystal structures of recombinant Geobacillus stearothermophilus 6-
phosphogluconate dehydrogenase (Gs6PDH) in complex with the substrate
6-phosphogluconate have been determined at medium resolution. Gs6PDH
shares signiﬁcant sequence identity and structural similarity with the enzymes
from Lactococcus lactis, sheep liver and the protozoan parasite Trypanosoma
brucei, for which a range of structures have previously been reported.
Comparisons indicate that amino-acid sequence conservation is more
pronounced in the two domains that contribute to the architecture of the active
site, namely the N-terminal and C-terminal domains, compared with the central
domain, which is primarily involved in the subunit–subunit associations required
to form a stable dimer. The active-site residues are highly conserved, as are the
interactions with the 6-phosphogluconate. There is interest in 6PDH as a
potential drug target for the protozoan parasite T. brucei, the pathogen
responsible for African sleeping sickness. The recombinant T. brucei enzyme has
proven to be recalcitrant to enzyme–ligand studies and a surrogate protein
might offer new opportunities to investigate and characterize 6PDH inhibitors.
The high degree of structural similarity, efﬁcient level of expression and
straightforward crystallization conditions mean that Gs6PDH may prove to be
an appropriate model system for structure-based inhibitor design targeting the
enzyme from Trypanosoma species.
1. Introduction
The enzyme 6-phosphogluconate dehydrogenase (6PDH; EC
1.1.1.44) catalyzes the conversion of 6-phosphogluconate (6PG) to
ribulose 5-phosphate (R5P), a reaction that occurs in the pentose
phosphate pathway that generates NADPH and pentose sugars
(Barrett, 1997). This is an essential activity in eukaryotic cells (Lobo
& Maitra, 1982; Hughes & Lucchesi, 1977) and the deleterious effects
generated by compromising 6PDH activity have been ascribed to the
disruption of glycolysis by 6PG inhibition of phosphoglucose
isomerase (Marchand et al., 1989). The essential nature of 6PDH
suggests that it is a potential drug target in Trypanosoma brucei,a
protozoan parasite that is responsible for African sleeping sickness
(Barrett, 1997). Further support for this conclusion comes from the
observation that selective inhibition of the parasite over mammalian
enzymes appears to be possible (Hanau et al., 2004). The structures of
6PDH from sheep (Oa6PDH; Adams et al., 1994), T. brucei
(Tb6PDH; Phillips et al., 1998), Lactococcus lactis (Ll6PDH;
Sundaramoorthy et al., 2007) and Saccharomyces cerevisiae (He et al.,
2007) have been reported.
Our studies with 6PDH from a variety of species, in particular the
T. brucei enzyme, have proven to be problematic, with limitations in
protein stability and solubility compounding difﬁculties in structural
studies. The enzyme from L. lactis enabled us to generate some data
on protein–ligand complexes (Tetaud et al., 1998; Sundaramoorthy et
al., 2007). However, this enzyme does not produce good-quality
crystals in a reproducible fashion and the presence of one long unit-
cell length (>240 A ˚ ) renders it difﬁcult to routinely measure
diffraction data to high resolution. An alternative source of suitablecrystals was sought to provide a surrogate model to assist structure-
based ligand studies that guide the development of novel inhibitors
(Hunter, 2009). The crystallization of 6PDH from the moderate
thermophile Geobacillus stearothermophilus has been reported
(Gs6PDH; Pearse & Harris, 1973) and we sought to establish whether
this particular enzyme would provide a useful source of crystals. We
now report the preparation of an efﬁcient recombinant protein-
production system, crystallization, structure determination and
comparisons with previously determined structures.
2. Methods and materials
2.1. Cloning, expression and purification
The gene encoding 6PDH was identiﬁed using a BLAST search
(Altschul et al., 1990), with sequence information based on 6PDH
from L. lactis (accession No. NP_266778), against the unﬁnished
G. stearothermophilus genome (http://www.genome.ou.edu/bstearo.
html). Genomic DNA from G. stearothermophilus (American Type
Culture Collection 12980) was used as template for PCR with the
following primers designed to amplify the 6PDH open reading frame
and incorporating NdeI and XhoI restriction sites (bold), respec-
tively: 50-CAT-ATG-GCT-AAA-CAG-CAA-ATC-GGC-G-30 and
50-CTC-GAG-TTA-TTT-CAA-CCA-TTC-CGT-ATG-30. The PCR
product was ligated into pCR-BluntII-TOPO vector using the Zero
Blunt TOPO PCR cloning kit (Invitrogen). Once identiﬁed, the gene
was excised with NdeI/XhoI and then ligated into a modiﬁed pET15b
vector (Novagen) in which the sequence that encodes a thrombin
protease cleavage site had been replaced with a tobacco etch virus
(TEV) protease recognition site. This plasmid therefore encodes a
product with an N-terminal hexahistidine tag, which is removed by
TEV protease. The plasmid was ampliﬁed in XL-1 Blue Escherichia
coli and the integrity of the PCR product was veriﬁed by sequencing
and then used to transform E. coli strain BL21 (DE3) pLysS for
protein production.
Bacteria were cultured with shaking at 200 rev min
 1 in auto-
induction media (Studier, 2005) with 50 mg l
 1 carbenicillin for
approximately 2 h at 310 K followed by 22 h at 295 K. Cells were
harvested by centrifugation (3500g, 20 min, 277 K) and resuspended
in 50 mM Tris–HCl pH 7.4, 250 mM NaCl. DNAse I (100 mg) and an
EDTA-free protease-inhibitor cocktail tablet (Roche) were added to
the mixture before the cells were lysed in a TS-75 cell disruptor
(Constant Systems) and the soluble fraction was isolated by centri-
fugation (50 000g, 30 min, 277 K). The cell extract was ﬁltered and
applied onto a HisTrap HP 5 ml column (GE Healthcare). The His-
tagged protein was eluted with a 0–1 M imidazole gradient in the
same buffer. Histidine-tagged TEV protease (1 mg in the same buffer
per 20 mg 6PDH) was added to the product and the mixture was
dialysed against the same buffer as used for cell lysis. Passage over a
His-Trap column removed the TEV protease, the cleaved His-tag
peptide and any 6PDH which retained the tag and the processed
6PDH was collected. A ﬁnal puriﬁcation step involved gel ﬁltration
(Superdex 200, 26/60 column, GE Healthcare) before buffer
exchange into 50 mM Tris–HCl pH 7.4, 20 mM NaCl and concen-
tration to 12 mg ml
 1 for crystallization trials. The high level of
protein purity was conﬁrmed by SDS–PAGE and matrix-assisted
laser desorption ionization–time-of-ﬂight mass spectrometry. The
yield of puriﬁed protein was approximately 20 mg per litre of
bacterial culture.
2.2. Crystallization, data collection and processing
Crystals grew over 2 d in hanging drops consisting of 1 ml protein
solution and 1 ml reservoir solution (0.2 M lithium sulfate, 2.2 M
ammonium sulfate or 0.2 M ammonium acetate, 2.2 M ammonium
sulfate) equilibrated against 500 ml reservoir solution at 293 K.
Crystals were also obtained in the presence of 2 mM 6PG and 2 mM
NADP
+ or 2 mM R5P and 2 mM NADP
+. Single crystals (blocks with
approximate dimensions 0.2   0.2   0.2 mm) were placed in a nylon
loop (Hampton Research), mounted on a goniostat, cooled to 100 K
with gaseous nitrogen and then characterized using a Micromax-007
rotating-anode generator and an R-AXIS IV
++ dual image-plate
detector (Rigaku). Suitable crystals were stored in liquid nitrogen
and X-ray diffraction data were then measured with a wavelength of
0.979 A ˚ and a Q315r charge-coupled device detector (Area Detector
Systems Corporation) on beamline ID14-4 of the European
Synchrotron Radiation Facility. Although all crystals were isomor-
phous, those grown in the presence of lithium sulfate diffracted to
higher resolution than those obtained with sodium acetate and so
they were used for the analyses. Two data sets were obtained: data set
I from a crystal (hereafter called crystal I) grown in the presence of
6PG which diffracted to 2.3 A ˚ resolution and data set II acquired
from two crystals grown in the presence of R5P which diffracted to
2.2 A ˚ resolution. The subsequent analysis of data set II revealed only
the presence of 6PG in the corresponding crystals.
Diffraction data from crystal I were processed using MOSFLM/
SCALA (Leslie, 2006; Evans, 2006), whilst data set II was generated
using XDS/XSCALE (Kabsch, 2001). Relevant results are shown in
Table 1.
2.3. Molecular replacement, model building and refinement
The data sets were processed and the structures solved and reﬁned
independently, but the same Rfree set was maintained. Both a poly-
alanine model and mixed model, with conserved residues left as they
are, based on an L. lactis 6PDH subunit (PDB code 1iyo) were
constructed using CHAINSAW from the CCP4 suite of programs
(Collaborative Computational Project, Number 4, 1994). These two
structural communications
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Table 1
Crystallographic statistics.
Values in parentheses are for the highest resolution shell bin with a width of 0.06 A ˚ .
Data set I Data set II
Space group P212121 P212121
Unit-cell parameters (A ˚ ) a = 67.04, b = 119.97,
c = 142.83
a = 66.95, b = 119.50,
c = 142.24
Resolution range (A ˚ ) 71.43–2.30 71.07–2.20
No. of unique reﬂections 52157 57708
Completeness of data (%) 99.9 (99.9) 99.3 (99.6)
hI/(I)i 14.1 (3.2) 10.4 (3.6)
R factor (%) 18.2 (23.2) 17.1 (26.3)
Rfree (%) 23.4 (30.8) 23.4 (36.3)
R.m.s.d from ideal values
Bond lengths (A ˚ ) 0.012 0.012
Angles ( ) 1.389 1.276
Average B values (A ˚ 2)
Protein 26.0 40.8
Main chain 25.5 39.5
Waters 26.6 42.1
Side chain 26.6 47.1
6PG [occupancy] 75.7 [1.0] 53.7 [0.7]
Wilson B (A ˚ 2) 28.8 31.4
Ramachandran plot analysis†
Most favoured regions 93.1 [757] 91.8 [752]
Additional allowed regions 6.2 [50] 7.3 [60]
Generously allowed 0.1 [1] 0.4 [3]
Disallowed regions 0.6 [5] 0.5 [4]
† The numbers in square brackets in the Ramachandran analysis are the number of
residues in each category.proteins share 66% sequence identity. These models were used for
molecular-replacement calculations in Phaser (McCoy et al., 2005) to
position the two subunits that constitute the asymmetric unit.
Reﬁnement was carried out using REFMAC5 (Murshudov et al.,
1997) interspersed with electron-density and difference density map
inspection, model manipulation and the incorporation of solvent and
ligands using Coot (Emsley & Cowtan, 2004). The asymmetric unit
consists of two monomers and they were treated independently
during reﬁnement. Crystallographic statistics are given in Table 1.
Figures were prepared with PyMOL (http://www.pymol.org) and
ALINE (Bond & Schu ¨ttelkopf, 2009).
3. Results and discussion
3.1. Structure determination
Two isomorphous crystal structures were determined (Table 1).
Data set I was obtained from a sample grown in the presence of 6PG
and NADP
+ and data set II was obtained from crystals grown in the
presence of R5P and NADP
+. In neither structure was there electron
density that could be attributed to NADP
+. In structure I, 6PG is
present in both active sites of the dimer that constitutes the asym-
metric unit. However, structure II contained only 6PG, not R5P, and
then only in one active site with a reduced occupancy of 0.7. This
value was assigned following several rounds of reﬁnement testing
different levels of occupancy to elucidate that which gave clean
difference density maps and thermal parameters consistent with the
amino-acid side chains in the vicinity of the ligand. We have no
deﬁnitive explanation of why we only see partially ordered 6PG in
one active site of structure II, although we note a difference in the
time that elapsed between crystal growth and cryo-freezing. Crystal I
was frozen and stored in liquid nitrogen within one week of setting up
the crystallization conditions. The crystals used to generate data set II
were frozen after a period of two months.
A pronounced similarity of the two subunits in the asymmetric
units of both crystals is observed despite not employing noncrys-
tallographic symmetry restraints during reﬁnement. The overlay of
467 C
 positions of structure I subunit A on subunit B results in an
r.m.s.d. of 0.53 A ˚ ; for structure II an r.m.s.d. of 0.70 A ˚ is observed
from the overlay of 470 C
 atoms. The models derived from the
independent analyses are also highly conserved. The overlay of the
structure I and structure II dimers, 935 C
 atoms, gives an r.m.s.d. of
0.29 A ˚ . In both structures Lys3, Gly137, Asp175 and Thr453 of both
subunits are in disallowed regions of the Ramachandran plot.
To all intents, the protein structures are identical. The only
signiﬁcant difference is that structure II only has 6PG in a single
activesiteandatareducedoccupancy.WethereforedetailstructureI.
3.2. Overall structure
Gs6PDH shows the same overall fold and three-domain archi-
tecture as the other 6PDH structures known (Fig. 1; Adams et al.,
1994; Sundaramoorthy et al., 2007). The N-terminal domain, which is
formed from the residues up to 174, harbours the site in which
NADP
+ binds. This domain adopts the Rossmann nucleotide-binding
domain fold. The central domain is a largely helical domain (ten
-helices, residues 175–433) that is primarily involved in dimer
formation. The C-terminal domain or ‘tail domain’ consists of a single
-helix followed by two -strands and extrudes from the central
domain deep into the partner subunit. The active site of 6PDH is
formed largely by residues contributed from the N-terminal domain
but with one side of the cleft lined by residues from the tail domain of
the partner subunit; this will be discussed later.
3.3. Structural and sequence comparisons
The G. stearothermophilus 6PDH models display high similarity to
the L. lactis, O. aries and T. brucei 6PDH structures (Fig. 2a). The
least-squares superpositions of C
 positions of subunit A of structure
I with a subunit of each of these orthologues results in r.m.s.d. values
of 1.51 A ˚ (461 residues), 0.90 A ˚ (464 residues) and 1.60 A ˚ (454
residues), respectively.
Gs6PDH shares 66% sequence identity with Ll6PDH and 57% and
36% identity with Oa6PDH and Tb6PDH, respectively. A sequence
alignment of these four enzymes is presented in Fig. 2(b). About 26%
of the residues are strictly conserved across all four sequences;
however, the level of conservation varies according to the domain. In
the N-terminal, central and tail domains there are 32, 21 and 36% of
structural communications
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Figure 1
Secondary and domain structure of Gs6PDH. (a) A ribbon diagram of one subunit.
The N-terminal domain is blue, the central domain is yellow and the C-terminal
domain is red. (b) Ribbon diagram of the dimer, coloured as in (a). The ligand 6PG
is shown as van der Waals spheres coloured black for C, red for O and orange for P.residues, respectively, that are strictly conserved. If this comparison is
restricted to the two bacterial enzymes the values are 66, 63 and 75%,
respectively. Comparison of the Gs6PDH and Tb6PDH sequences
reveals values of 49, 26 and 44% for the three domains. The N-
terminal and tail domains contribute to the creation of the active site
and display a higher level of sequence conservation compared with
the central domain, which contributes to dimer formation.
Cofactor binding to 6PDH occurs in a groove on the periphery of
the N-terminal domain, with the adenine ribose placed at the 1–1
turn that carries a nucleotide-binding motif. In Gs6PDH the sequence
is Gly10-Leu11-Ala12-Val13-Met14-Gly15 and this matches closely
with that observed in most organisms: a Gly-X-Ala-X-X-Gly motif. In
Tb6PDH the motif is altered to Gly-X-Gly-X-X-Gly (Phillips et al.,
1998; Fig. 2b). At present it is unclear whether this glycine–alanine
difference will inﬂuence the catalytic properties of the respective
enzymes or lead to structural differences when the cofactor is bound.
Further structures of both Tb6PDH and Gs6PDH in complex with
the cofactor would be required in order to address this point.
3.4. Ligand binding
The interactions formed by 6PG with 6PDH have previously been
detailed for the L. lactis enzyme and compared with other structures
(Sundaramoorthy et al., 2007). The 6PG substrate-binding site of
Gs6PDH and the interactions formed with this ligand (Fig. 3) are
highly conserved in other 6PDH structures. The phosphate of 6PG is
positioned by accepting hydrogen bonds from Tyr190, Lys260,
Arg287 of one subunit and Arg446 of the partner subunit. Ordered
structural communications
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Figure 2
Comparison of the primary and secondary structures of Gs6PDH, Ll6PDH, Tb6PDH and Oa6PDH. (a) Stereoview C
 trace of Gs6PDH (grey) superimposed on Ll6PDH
(black) and Tb6PDH (red). (b) Sequence alignment of four 6PDH enzymes, with the assigned secondary structure of Gs6PDH (cylinders. -helices; arrows, -strands).
Strictly conserved residues are shown in black boxes.water-mediated hydrogen bonds also link the phosphate group to
Asn186, Glu189 and Thr262. Additional hydrogen bonds, including
several water-mediated interactions, involving His552 from one
subunit and Asn102, Ser128, Gly129, Gly130 and Asn186 from the
partner hold the rest of the ligand in place. These residues include
two that have been shown to be critical for the enzyme mechanism,
Lys182 (Zhang et al., 1999) and Glu189 (Karsten et al., 1998), and
others (for example, Ser128, Asn187 and His186) that are responsible
for ligand binding and catalysis (Li, Dworkowski et al., 2006; Li,
Zhang et al., 2006). All of these 13 residues are strictly conserved in
the 6PDH sequences from diverse species ranging from a higher
eukaryote to a protozoan eukaryote and two different Gram-positive
bacteria. Such a high level of sequence and structural conservation
suggests that Gs6PDH could serve as an appropriate surrogate for
structure-based ligand design targeting the pathogenic protozoan
T. brucei.
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Figure 3
The 6PG-binding site of Gs6PDH and comparison with Ll6PDH. (a)T h eGs6PDH
active site. Atoms are coloured according to type: N, blue; O, red; P, orange; the C
atoms of residues associated with subunit A are shown in grey, those associated
with subunit B are shown in yellow and those in the ligand are shown in black.
Water molecules are depicted as blue spheres and dashed lines indicate potential
hydrogen-bonding interactions. (b)T h eLl6PDH active site in a similar orientation
and representation. For the purpose of clarity, water molecules and associated
hydrogen-bond interactions have been omitted from this ﬁgure.